####################
# Output from PRIME (v2.0)
# Alleles: C0202
# Affinity predictions: MixMHCpred (/Users/annieborch/Documents/programs/MixMHCpred-master/MixMHCpred)
# Input file: /Users/annieborch/Documents/IMPROVE/IMPROVE_git/IMPROVE_tool/results/predictions/PRIME/tempPept.txt
#
# PRIME is freely available for academic users.
# Private companies should contact Nadette Bulgin (nbulgin@lcr.org) at the Ludwig Institute for Cancer Research Ltd for commercial licenses.
# To cite PRIME2.0, please refer to:
# Gfeller et al. Predictions of immunogenicity reveal potent SARS-Cov-2 CD8 T-cell epitopes, BioRxiv (2022).
####################
Peptide	%Rank_bestAllele	Score_bestAllele	%RankBinding_bestAllele	BestAllele	%Rank_C0202	Score_C0202	%RankBinding_C0202
KMEQEMTWL	8.960	0.004986	13.147	C0202	8.960	0.004986	13.147
SSPSFYRAL	0.527	0.067462	0.956	C0202	0.527	0.067462	0.956
FVDTMVHQAI	6.110	0.007580	9.925	C0202	6.110	0.007580	9.925
RTLIYAHLL	1.147	0.038081	4.715	C0202	1.147	0.038081	4.715
